NexgenRX Inc. (V:NXG) — Market Cap & Net Worth
Market Cap & Net Worth: NexgenRX Inc. (NXG)
NexgenRX Inc. (V:NXG) has a market capitalization of $22.64 Million (CA$31.29 Million) as of June 16, 2026. Listed on the V stock exchange, this Canada-based company holds position #24736 globally and #955 in its home market, demonstrating a 3.53% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying NexgenRX Inc.'s stock price CA$0.44 by its total outstanding shares 71117132 (71.12 Million). Review NXG current and long-term liabilities to assess the company's total debt and financial obligations.
NexgenRX Inc. Market Cap History: 2015 to 2026
NexgenRX Inc.'s market capitalization history from 2015 to 2026. Data shows growth from $8.02 Million to $22.64 Million (11.53% CAGR).
NexgenRX Inc. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how NexgenRX Inc.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.86x
NexgenRX Inc.'s market cap is 0.86 times its annual revenue
Latest Price to Earnings (P/E) Ratio
23.02x
NexgenRX Inc.'s market cap is 23.02 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $8.02 Million | $4.66 Million | -$188.32K | 1.72x | N/A |
| 2016 | $11.32 Million | $5.75 Million | $587.80K | 1.97x | 19.25x |
| 2017 | $11.32 Million | $5.67 Million | -$625.91K | 2.00x | N/A |
| 2018 | $12.26 Million | $7.17 Million | -$696.86K | 1.71x | N/A |
| 2019 | $9.44 Million | $9.54 Million | -$207.94K | 0.99x | N/A |
| 2020 | $11.32 Million | $11.04 Million | $2.12 Million | 1.03x | 5.35x |
| 2021 | $18.86 Million | $11.84 Million | $4.02 Million | 1.59x | 4.70x |
| 2022 | $13.12 Million | $12.78 Million | -$22.40K | 1.03x | N/A |
| 2023 | $11.12 Million | $13.85 Million | -$331.97K | 0.80x | N/A |
| 2024 | $14.15 Million | $16.48 Million | $614.57K | 0.86x | 23.02x |
Competitor Companies of NXG by Market Capitalization
Companies near NexgenRX Inc. in the global market cap rankings as of June 16, 2026.
Key companies related to NexgenRX Inc. by market ranking:
- Veeva Systems Inc Class A (NYSE:VEEV): Ranked #1025 globally with a market cap of $26.34 Billion USD.
- Pro Medicus Ltd (AU:PME): Ranked #1952 globally with a market cap of $12.16 Billion USD ( AU$17.19 Billion AUD).
- BrightSpring Health Services, Inc. Common Stock (NASDAQ:BTSG): Ranked #2170 globally with a market cap of $10.63 Billion USD.
- Tempus AI, Inc. Class A Common Stock (NASDAQ:TEM): Ranked #2418 globally with a market cap of $9.09 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #1025 | Veeva Systems Inc Class A | NYSE:VEEV | $26.34 Billion | $162.17 |
| #1952 | Pro Medicus Ltd | AU:PME | $12.16 Billion | AU$164.55 |
| #2170 | BrightSpring Health Services, Inc. Common Stock | NASDAQ:BTSG | $10.63 Billion | $64.08 |
| #2418 | Tempus AI, Inc. Class A Common Stock | NASDAQ:TEM | $9.09 Billion | $52.32 |
NexgenRX Inc. Historical Marketcap From 2015 to 2026
Between 2015 and today, NexgenRX Inc.'s market cap moved from $8.02 Million to $ 22.64 Million, with a yearly change of 11.53%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CA$22.64 Million | +10.00% |
| 2025 | CA$20.58 Million | +45.45% |
| 2024 | CA$14.15 Million | +27.26% |
| 2023 | CA$11.12 Million | -15.29% |
| 2022 | CA$13.12 Million | -30.43% |
| 2021 | CA$18.86 Million | +66.68% |
| 2020 | CA$11.32 Million | +19.96% |
| 2019 | CA$9.44 Million | -23.07% |
| 2018 | CA$12.26 Million | +8.36% |
| 2017 | CA$11.32 Million | 0.00% |
| 2016 | CA$11.32 Million | +41.12% |
| 2015 | CA$8.02 Million | -- |
End of Day Market Cap According to Different Sources
On Jun 16th, 2026 the market cap of NexgenRX Inc. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $22.64 Million USD |
| MoneyControl | $22.64 Million USD |
| MarketWatch | $22.64 Million USD |
| marketcap.company | $22.64 Million USD |
| Reuters | $22.64 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About NexgenRX Inc.
NexgenRx Inc. administers, adjudicates, and pays drug, dental, and other extended health-care claims for the beneficiaries of health benefit plans underwritten by its customers in Canada. The company offers NexSys claims management; NexAdmin plan administration; and NexPSPAssist patient support programs. It also provides ancillary services. NexgenRx Inc. was incorporated in 2003 and is headquarte… Read more